{"id":{"repo_id":"ethz","oai_identifier":"oai:www.research-collection.ethz.ch:20.500.11850/155107"},"canonical_url":"https://search.dev.ndltd.org/etd/ethz/oai:www.research-collection.ethz.ch:20.500.11850/155107","repository":{"repo_id":"ethz","name":"ETH Zürich","base_url":"https://www.research-collection.ethz.ch/oai/request"},"display":{"title":"Multidimensionale Erkennung im strukturbasierten Wirkstoffdesign: Synthese und Evaluation von Proteinkinase- und Fettsäuresynthase-Inhibitoren","abstract":"","abstract_html":null,"abstract_has_math":false,"creators":["Lauber, Birgit Sophia"],"institution":"ETH Zurich","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Diederich, François; id_orcid0000-0003-1947-6327","Kast, Peter Andreas"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015","date_published":"2015","updated_at":"2026-07-27T19:27:05Z","subjects":["PROTEINKINASEN (SIGNALTRANSDUKTION, BIOLOGIE); FETTSÄURENBIOSYNTHESE + FETTSÄURENANABOLISMUS (METABOLISMUS); PROTEINE, POLYPEPTIDE, ENZYME, ENZYMINHIBITOREN, PEPTIDE (PHARMAZIE); KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; PROTEIN KINASES (SIGNAL TRANSDUCTION, BIOLOGY); FATTY ACID BIOSYNTHESIS + FATTY ACID ANABOLISM (METABOLISM); PROTEINS, POLYPEPTIDES, ENZYMES, ENZYME INHIBITORS, PEPTIDES (PHARMACY); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY)","info:eu-repo/classification/ddc/610","Medical sciences, medicine"],"languages":["en"],"rights":["info:eu-repo/semantics/openAccess","In Copyright - Non-Commercial Use Permitted"],"rights_urls":["http://rightsstatements.org/page/InC-NC/1.0/"],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://doi.org/10.3929/ethz-a-010443467"],"render_values":[{"text":"https://doi.org/10.3929/ethz-a-010443467","href":"https://doi.org/10.3929/ethz-a-010443467","code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/20.500.11850/155107","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Diederich, François; id_orcid0000-0003-1947-6327","Kast, Peter Andreas"]},{"key":"dc:creator","label":"Author","values":["Lauber, Birgit Sophia"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2015","info:eu-repo/date/embargoEnd/2018-05-26"]},{"key":"dc:publisher","label":"Institution","values":["ETH Zurich"]},{"key":"dc:type","label":"Dc Type","values":["info:eu-repo/semantics/doctoralThesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["PROTEINKINASEN (SIGNALTRANSDUKTION, BIOLOGIE); FETTSÄURENBIOSYNTHESE + FETTSÄURENANABOLISMUS (METABOLISMUS); PROTEINE, POLYPEPTIDE, ENZYME, ENZYMINHIBITOREN, PEPTIDE (PHARMAZIE); KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; PROTEIN KINASES (SIGNAL TRANSDUCTION, BIOLOGY); FATTY ACID BIOSYNTHESIS + FATTY ACID ANABOLISM (METABOLISM); PROTEINS, POLYPEPTIDES, ENZYMES, ENZYME INHIBITORS, PEPTIDES (PHARMACY); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY)","info:eu-repo/classification/ddc/610","Medical sciences, medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["info:eu-repo/semantics/openAccess","http://rightsstatements.org/page/InC-NC/1.0/","In Copyright - Non-Commercial Use Permitted"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/20.500.11850/155107","https://doi.org/10.3929/ethz-a-010443467"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:format","label":"Dc Format","values":["application/application/pdf"]},{"key":"dc:title","label":"Title","values":["Multidimensionale Erkennung im strukturbasierten Wirkstoffdesign: Synthese und Evaluation von Proteinkinase- und Fettsäuresynthase-Inhibitoren"]}]}],"canonical_facts":{"dc:contributor":["Diederich, François; id_orcid0000-0003-1947-6327","Kast, Peter Andreas"],"dc:creator":["Lauber, Birgit Sophia"],"dc:date":["2015","info:eu-repo/date/embargoEnd/2018-05-26"],"dc:format":["application/application/pdf"],"dc:identifier":["http://hdl.handle.net/20.500.11850/155107","https://doi.org/10.3929/ethz-a-010443467"],"dc:language":["en"],"dc:publisher":["ETH Zurich"],"dc:rights":["info:eu-repo/semantics/openAccess","http://rightsstatements.org/page/InC-NC/1.0/","In Copyright - Non-Commercial Use Permitted"],"dc:subject":["PROTEINKINASEN (SIGNALTRANSDUKTION, BIOLOGIE); FETTSÄURENBIOSYNTHESE + FETTSÄURENANABOLISMUS (METABOLISMUS); PROTEINE, POLYPEPTIDE, ENZYME, ENZYMINHIBITOREN, PEPTIDE (PHARMAZIE); KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; PROTEIN KINASES (SIGNAL TRANSDUCTION, BIOLOGY); FATTY ACID BIOSYNTHESIS + FATTY ACID ANABOLISM (METABOLISM); PROTEINS, POLYPEPTIDES, ENZYMES, ENZYME INHIBITORS, PEPTIDES (PHARMACY); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY)","info:eu-repo/classification/ddc/610","Medical sciences, medicine"],"dc:title":["Multidimensionale Erkennung im strukturbasierten Wirkstoffdesign: Synthese und Evaluation von Proteinkinase- und Fettsäuresynthase-Inhibitoren"],"dc:type":["info:eu-repo/semantics/doctoralThesis"]},"updated_at":"2026-07-27T19:27:05Z"}